![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 9/08 | |
A61K 47/36 | |||
A61K 47/02 | |||
A61K 47/18 | |||
A61K 47/34 | |||
A61K 47/40 | |||
A61K 47/44 | |||
A61K 31/335 | |||
A61K 31/551 | |||
A61K 9/00 |
(11) | Number of the document | 2811979 |
(13) | Kind of document | T |
(96) | European patent application number | 13706360.8 |
Date of filing the European patent application | 2013-02-08 | |
(97) | Date of publication of the European application | 2014-12-17 |
(45) | Date of publication and mention of the grant of the patent | 2018-05-02 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2013/025376 |
Date | 2013-02-08 |
(87) | Number | WO 2013/119974 |
Date | 2013-08-15 |
(30) | Number | Date | Country code |
201261597416 P | 2012-02-10 | US |
(72) |
MEADOWS, David L., US
KETELSON, Howard Allen, US
DAVIS, James W., US
CHIOU, Jang-Shing, US
|
(73) |
NOVARTIS AG,
Lichtstrasse 35, 4056 Basel,
CH
|
(54) | AQUEOUS PHARMACEUTICAL COMPOSITION WITH ENHANCED STABILITY |
AQUEOUS PHARMACEUTICAL COMPOSITION WITH ENHANCED STABILITY |